Last reviewed · How we verify
Anti-scorpion venom serum Alacramyn — Competitive Intelligence Brief
phase 3
Antivenom serum
Toxicology / Emergency Medicine
Biologic
Live · refreshed every 30 min
Target snapshot
Anti-scorpion venom serum Alacramyn (Anti-scorpion venom serum Alacramyn) — Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.. Alacramyn is an antivenom serum that neutralizes scorpion venom toxins through specific antibodies that bind to and inactivate venom components.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Anti-scorpion venom serum Alacramyn TARGET | Anti-scorpion venom serum Alacramyn | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. | phase 3 | Antivenom serum |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antivenom serum class)
- Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Anti-scorpion venom serum Alacramyn CI watch — RSS
- Anti-scorpion venom serum Alacramyn CI watch — Atom
- Anti-scorpion venom serum Alacramyn CI watch — JSON
- Anti-scorpion venom serum Alacramyn alone — RSS
- Whole Antivenom serum class — RSS
Cite this brief
Drug Landscape (2026). Anti-scorpion venom serum Alacramyn — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-scorpion-venom-serum-alacramyn. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab